Schedule:
Monday - Saturday - 0:00 - 0:00, Sunday - 0:00 - 0:00
  info@dummymail.com
  1237 654 443
  Login
Donate
Registry WebLink
Toggle navigation
Home
About Us
Who We Are
Advisory Board
Participating/Executive Members
Annual Returns and Reports
Member Institutions
Research
Research
SOP for Multicenter Studies
Ongoing Studies
Publication & Abstracts
Publication
Abstracts
Membership
Membership Information
Individual
Online Registration
List of Individual Members
Institutional
Online Registration
Education
Physician Webinar
Nursing Webinar
DEO Training
Guidelines
Patient Resources
Patient Education Booklet
English
Hindi
Marathi
Malayalam
Kannada
Support Group Meeting
Patient Advocacy Team
Patient Stories
Useful Links
News & Events
Announcements
Newsletter Archives
Annual Conference
2019
Conference presentations
2022
Scientific Program
Nurses Workshop
DEO Training Workshop
Patient Advocacy Session
Gallery
Day 1
Day 2
Day 3
Connect with us
Contact Us
Donate
Scientific Program
Acute Lymphoblastic Leukemia
Know More
Topic:
CAR-T Cell Therapy in ALL: Current status and future directions
Presenter:
Dr. Nitin Jain
Institute:
MD Anderson Cancer Centre, Houston, TX, United States
Know More
Topic:
Improving Access to CAR-T Cell Therapy
Presenter:
Dr. Boro Dropulic
Institute:
Caring Cross, Gaithersburg, MD, United States
Know More
Topic:
Ph Positive ALL Therapy
Presenter:
Dr. Sushil Selvarajan
Institute:
Christian Medical College Vellore
Know More
Topic:
ALL Biology
Presenter:
Dr. Madhavi Maddali
Institute:
Christian Medical College Vellore
Know More
Topic:
T-cell ALL
Presenter:
Dr. Parathan Karunakaran
Institute:
Cancer Institute Adyar
Know More
Topic:
HCC ALL Registry Data
Presenter:
Dr. Dinesh Bhurani
Institute:
Rajiv Gandhi Cancer Institute & Research Center
Know More
Topic:
Panel discussion: ALL: Questions for which you want answers
Presenter:
Dr. Prasanth Ganesan
Institute:
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)
Chronic Myeloid Leukemia
Topic:
How I Treat CML at MD Anderson in 2022
Presenter:
Dr. Elias Jabbour
Institute:
MD Anderson Cancer Centre, Houston, TX, United States
Know More
Topic:
Novel Therapies Beyond Ponatinib
Presenter:
Dr. Jina Bhattacharya
Institute:
Gauhati Medical College
Know More
Topic:
CML and TFR
Presenter:
Dr. Neha Vyas
Institute:
St. John's Research Institute (SJRI), Bangalore
Know More
Topic:
HCC GLaD Study Interim Results
Presenter:
Dr. Aby Abraham
Institute:
Christian Medical College Vellore
Know More
Topic:
Panel discussion: Evidence Based Management of CML in the Real World
Presenter:
Dr. Atul Sharma
Institute:
All India Institute of Medical Sciences
Acute Myeloid Leukemia
Know More
Topic:
Relapse Refractory AML: Current treatment strategies
Presenter:
Dr. Farhad Ravandi Kashani
Institute:
MD Anderson Cancer Centre, Houston, TX, United States
Know More
Topic:
Translating the Current Evidence to Resource Constraint Setting
Presenter:
Dr. Naval Daver
Institute:
MD Anderson Cancer Center, Houston, TX, United States
Know More
Topic:
AML Maintenance Therapy
Presenter:
Dr. Uday Kulkarni
Institute:
Christian Medical College, Vellore
Know More
Topic:
AML Biology
Presenter:
Dr. Arun Kumar Arunachalam
Institute:
Christian Medical College, Vellore
Know More
Topic:
HCC AML pRISM-S Study
Presenter:
Dr. Smita Kayal
Institute:
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)
Know More
Topic:
Panel discussion: AML current management day to day practice challenges
Presenter:
Dr. Vikram Mathews
1
, Dr. Rajan Kapoor
2
Institute:
Christian Medical College, Vellore
1
, Army Hospital RR, New Delhi
2
Multiple Myeloma
Know More
Topic:
How to make Multiple Myeloma Care more Equitable Globally?
Presenter:
Dr. Shaji Kumar
Institute:
Mayo Clinic, Rochester, Minnesota, United States
Know More
Topic:
Smouldering Multiple Myeloma
Presenter:
Dr. Lingaraj Nayak
Institute:
Tata Memorial Hospital, Mumbai
Know More
Topic:
Amyloidosis
Presenter:
Dr. Uday Yanamandra
Institute:
AFMC, Army R&R
Know More
Topic:
Myeloma Biology
Presenter:
Dr. Nikita Mehra
1
, Dr. Rajan Kapoor
2
Institute:
Cancer Institute Adyar
1
, Army Hospital RR, New Delhi
2
Know More
Topic:
Multiple Myeloma Measurable Residual Disease
Presenter:
Dr. Prashant Tembhare
Institute:
Tata Memorial Center, Mumbai
Know More
Topic:
Panel discussion: Multiple Myeloma discussion
Presenter:
Dr. Pankaj Malhotra
Institute:
Postgraduate Institute of Medical Education & Research(PGIMER), Chandigarh
Non-Hodgkin lymphoma
Know More
Topic:
CAR-T Cell Therapy
Presenter:
Dr. Sreeraj Vasudevan
Institute:
Amala Institute of medical sciences
Know More
Topic:
CAR T-cell therapy in lymphoma: Resistance mechanisms and next steps
Presenter:
Dr. Sattva S. Neelapu
Institute:
MD Anderson Cancer Centre, Houston, TX, United States
Know More
Topic:
Mantle Cell Lymphoma and Follicular Lymphoma
Presenter:
Dr. Esha Kaul
Institute:
Max Super Speciality Hospital
Know More
Topic:
Peripheral T Cell Lymphoma
Presenter:
Dr. Akash Kumar Jha
Institute:
All India Institute of Medical Sciences, New Delhi
Know More
Topic:
Hodgkin Lymphoma
Presenter:
Dr. Aparna Sharma
Institute:
All India Institute of Medical Sciences, New Delhi
Know More
Topic:
Panel discussion: Lymphomas: What is Relevant in the Clinics
Presenter:
Dr. Gaurav Prakash
Institute:
Post-Graduate Institute of Medical Education and Research, PGIMER
Myeloproliferative Neoplasm
Topic:
Molecular Signature of MPNs and its Significance
Presenter:
Dr. Ayalew Tefferi
Institute:
Mayo Clinic, Rochester, Minnesota
Know More
Topic:
Current Management of MDS
Presenter:
Dr Abhay A. Bhave
Institute:
Lilavati hospital, Global hospitals, Empire Haem Onc clinic, Mumbai
×
CAR-T Cell Therapy in ALL: Current status and future directions - Dr. Nitin Jain
No Support
×
Improving Access to CAR-T Cell Therapy - Dr. Boro Dropulic
No Support
×
Ph Positive ALL Therapy - Dr. Sushil Selvarajan
No Support
×
ALL Biology - Dr. Madhavi Maddali
No Support
×
T-cell ALL - Dr. Parathan Karunakaran
No Support
×
HCC ALL Registry Data - Dr. Dinesh Bhurani
No Support
×
Panel discussion: ALL: Questions for which you want answers - Dr. Prasanth Ganesan
No Support
×
How I Treat CML at MD Anderson in 2022 - Dr. Elias Jabbour
No Support
×
Novel Therapies Beyond Ponatinib - Dr. Jina Bhattacharya
No Support
×
CML and TFR - Dr. Neha Vyas
No Support
×
HCC GLaD Study Interim Results - Dr. Aby Abraham
No Support
×
Panel discussion: Evidence Based Management of CML in the Real World - Dr. Atul Sharma
No Support
×
Relapse Refractory AML: Current treatment strategies - Dr. Farhad Ravandi Kashani
No Support
×
Translating the Current Evidence to Resource Constraint Setting - Dr. Naval Daver
No Support
×
AML Maintenance Therapy - Dr. Uday Kulkarni
No Support
×
AML Biology - Dr. Arun Kumar Arunachalam
No Support
×
HCC AML pRISM-S Study - Dr. Smita Kayal
No Support
×
Panel discussion: AML current management day to day practice challenges - Dr. Vikram Mathews & Dr. Rajan Kapoor
No Support
×
How to make Multiple Myeloma Care more Equitable Globally? - Dr. Shaji Kumar
No Support
×
Smouldering Multiple Myeloma - Dr. Lingaraj Nayak
No Support
×
Amyloidosis - Dr. Uday Yanamandra
No Support
×
Myeloma Biology - Dr. Nikita Mehra & Dr. Rajan Kapoor
No Support
×
Multiple Myeloma Measurable Residual Disease - Dr. Prashant Tembhare
No Support
×
Panel discussion: Multiple Myeloma discussion - Dr. Pankaj Malhotra
No Support
×
CAR-T Cell Therapy - Dr. Sreeraj Vasudevan
No Support
×
CAR T-cell therapy in lymphoma: Resistance mechanisms and next steps - Dr. Sattva S. Neelapu
No Support
×
Mantle Cell Lymphoma and Follicular Lymphoma - Dr. Esha Kaul
No Support
×
Peripheral T Cell Lymphoma - Dr. Akash Kumar Jha
No Support
×
Hodgkin Lymphoma - Dr. Aparna Sharma
No Support
×
Panel discussion: Lymphomas: What is Relevant in the Clinics - Dr. Gaurav Prakash
No Support
×
Molecular Signature of MPNs and its Significance - Dr. Ayalew Tefferi
No Support
×
Current Management of MDS - Dr Abhay A. Bhave
No Support